Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Clinical trial NCT02834052 · COMPLETED

Trial details

NCT number: NCT02834052
Sponsor: Asha Nayak
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colon Cancer Solid Tumor

Start date: 2018-01-10
Primary completion: 2022-07-29
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.